Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Neumann

Showing results (361-370 of 404) with videos related to

Pageof 41
Sort By:
Allergy|January 21, 2022
Differential effects of lung inflammation on insulin resistance in humans and miceRuth Karlina, Claudia Flexeder, Stephanie Musiol, et al.
Transplantation|June 27, 1997
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantationJ M Langrehr, N C Nüssler, U Neumann, et al.
Allergy|June 5, 2020
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factorsUrszula Radzikowska, Mei Ding, Ge Tan, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2020
Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposureMehmet Gökkaya, Athanasios Damialis, Thomas Nussbaumer, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Gastroenterology|March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signalingJordan J Feld, Glen A Lutchman, Theo Heller, et al.
Plos One|February 26, 2013
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infectionJonas Söderholm, Jesper Waldenström, Galia Askarieh, et al.
Plos One|June 30, 2021
Human mobility at Tell Atchana (Alalakh), Hatay, Turkey during the 2nd millennium BC: Integration of isotopic and genomic evidenceTara Ingman, Stefanie Eisenmann, Eirini Skourtanioti, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infectionMartin Lagging, Ana I Romero, Johan Westin, et al.
Nature Medicine|November 1, 1996
The role of a mutant CCR5 allele in HIV-1 transmission and disease progressionY Huang, W A Paxton, S M Wolinsky, et al.
Pageof 41

Showing results (361-370 of 404) with videos related to

Sort By:
Pageof 41
Allergy|January 21, 2022
Differential effects of lung inflammation on insulin resistance in humans and miceRuth Karlina, Claudia Flexeder, Stephanie Musiol, et al.
Transplantation|June 27, 1997
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantationJ M Langrehr, N C Nüssler, U Neumann, et al.
Allergy|June 5, 2020
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factorsUrszula Radzikowska, Mei Ding, Ge Tan, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2020
Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposureMehmet Gökkaya, Athanasios Damialis, Thomas Nussbaumer, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Gastroenterology|March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signalingJordan J Feld, Glen A Lutchman, Theo Heller, et al.
Plos One|February 26, 2013
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infectionJonas Söderholm, Jesper Waldenström, Galia Askarieh, et al.
Plos One|June 30, 2021
Human mobility at Tell Atchana (Alalakh), Hatay, Turkey during the 2nd millennium BC: Integration of isotopic and genomic evidenceTara Ingman, Stefanie Eisenmann, Eirini Skourtanioti, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infectionMartin Lagging, Ana I Romero, Johan Westin, et al.
Nature Medicine|November 1, 1996
The role of a mutant CCR5 allele in HIV-1 transmission and disease progressionY Huang, W A Paxton, S M Wolinsky, et al.
Pageof 41